Ionis Pharmaceuticals, Inc. (IONS) Operating income 2016–2025
Ionis Pharmaceuticals, Inc. (IONS) annual operating income history from SEC filings — each fiscal year as reported.
-$381.7MFY2025 · since FY2016: -$20.2M → -$381.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$381.7M | +19.7% |
| FY2024 | -$475.1M | -34.3% |
| FY2023 | -$353.7M | +13.8% |
| FY2022 | -$410.2M | -1258.9% |
| FY2021 | -$30.2M | +82.5% |
| FY2020 | -$172.1M | -147.0% |
| FY2019 | $365.9M | +696.2% |
| FY2018 | -$61.4M | -297.7% |
| FY2017 | $31.0M | +254.0% |
| FY2016 | -$20.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice